Rocuronium Bromide Injection
Product Images NDC 43547-531

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 43547-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of rocuronium bromide, the active ingredient in ROCURONIUM BROMIDE injection. The diagram shows the molecular arrangement, including functional groups and bromide ion (Br-).*
FDA Label Image

Figures 1 (Image 02)

Figures 1 (Image 02)
Box plot graph showing the distribution of minutes on the y-axis versus rocuronium bromide dosage in mg/kg on the x-axis for three age groups: 18-64 years, 65 years and older, and 1-12 years. The graph includes grouped dosage points from 0.45 to 1.2 mg/kg with individual data points scattered around the box plots representing variability within each group.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
This box plot chart displays the duration in minutes on the y-axis against varying dosages (mg/kg) of rocuronium bromide on the x-axis across different age groups: 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years. It visually represents the variability and range of response times to rocuronium bromide injection by dose and age.*
FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
A line graph depicting the relationship between dose number and time in minutes for Rocuronium Bromide dosages of 0.1 mg/kg and 0.15 mg/kg. The vertical axis represents time in minutes (0 to 30), and the horizontal axis shows dose number (0 to 6). Two lines plot time for each dosage, showing general trends over multiple doses with sample sizes of 29 for 0.1 mg/kg and 13 for 0.15 mg/kg.*
FDA Label Image

50 mg/5 mL Vial (Image 05)

50 mg/5 mL Vial (Image 05)
Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) multiple dose vial. The label warns that the product is a paralyzing agent. It specifies sterile, nonpyrogenic, and for intravenous use only. The label includes storage instructions and distributor information for Solco Healthcare US, LLC.*
FDA Label Image

50 mg/5 mL Carton (Image 06)

50 mg/5 mL Carton (Image 06)
Packaging label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) by Solco Healthcare US, LLC. The label states it is for intravenous use only and contains 10 x 5 mL multiple-dose vials. The label includes a warning that the product is a paralyzing agent and provides storage information and manufacturer details from Zhejiang Huahai Pharmaceutical Co., Ltd., China.*
FDA Label Image

Peel Off Label 10 mg/ml (Image 07)

Peel Off Label 10 mg/ml (Image 07)
Packaging label for Rocuronium Bromide Injection, showing a concentration of 10 mg/mL. The label indicates it is for intravenous use only and prescription use only. Instructions on the label mention peeling off to apply to syringe. The background color is red with black text.*
FDA Label Image

100 mg/10 mL Vial (Image 08)

100 mg/10 mL Vial (Image 08)
Label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) by Solco Healthcare US, LLC. The label indicates this is a sterile, nonpyrogenic, intravenous injection provided as a 10 mL multiple dose vial. It includes warnings that it is a paralyzing agent causing respiratory arrest and must be used with facilities for artificial respiration available. Storage instructions specify refrigeration and room temperature conditions.*
FDA Label Image

100 mg/10 mL Carton (Image 09)

100 mg/10 mL  Carton (Image 09)
Packaging label for Rocuronium Bromide Injection, 100 mg/10 mL (10 mg/mL) multiple-dose vials. The label highlights intravenous use only and includes warnings about the drug being a paralyzing agent. The label shows the product name, strength, dosage form, manufacturer Zhejiang Huahai Pharmaceutical Co., Ltd., and distributor Solco Healthcare US, LLC. Storage instructions and a barcode are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.